Changes
/* Historic Sales */
===Historic Sales===
* The Acne Treatment Manufacturing OTC industry has maintained strong growth during the past five years. From 2007 to 2012, revenue has grown unabatedsteady, and it is expected to expand grow at an average annual rate of 2.4% to $2.3 billion.
* Because acne-prone individuals consider treatment products a necessary expense, revenue continued to rise during the recession, though growth did slow as consumers switched to more inexpensive products.
